Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29 And 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended

 Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2022 ,inter alia, to consider and approve The following business: 1.Proposal for issuance of Equity Shares and / or other securities of the Company by way of preferential issue or through any other permissible mode and / or combination thereof as may be considered appropriate to promoters and non-promoters, subject to such approvals as may be required under applicable laws including the approval of shareholders of the Company and also decide the matters consequential thereto. 2. Any other matters with the permission of the Chair. Notice is also given that pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations and in pursuant to Companies Code of Conduct for prevention of Insider Trading in Shares of the Company, the Trading window for dealing in the securities of the Company for all the designated persons including insiders has been closed and the same shall be closed till the conclusion of 48 hours of submission of outcome of the said meeting to the Stock Exchange. Please take on record.
20-08-2022
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 We hereby wish to inform you that the unaudited financial results (Standalone & Consolidated) for the quarter ended 30th June, 2022 were approved at the meeting of Board of Directors held on Saturday, 13th August, 2022. In continuation to the same, the newspaper clipping duly published in English and Gujarati Newspaper is enclosed herewith. This is for your information and records.
16-08-2022
Bigul

Medico Intercontinental Ltd - 539938 - Results - Financial Results For The Quarter Ended 30/06/2022

 Dear Sir/Ma'am, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., August 13, 2022, inter alia, considered and approved the matters as per attached PDF. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results along with Limited Review Report' for the quarter ended on June 30, 2022 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 P.M. and concluded at 02:30 P.M. This is for your information and records.
13-08-2022
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.

 Dear Sir/Ma'am, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., August 13, 2022, inter alia, considered and approved the matter as per the attached PDF. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results along with Limited Review Report' for the quarter ended on June 30, 2022 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 P.M. and concluded at 02:30 P.M. This is for your information and records.
13-08-2022
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 ,inter alia, to consider and approve Dear Sir/Ma'am, With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 13th August, 2022 at the registered office of the Company situated at 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat - 380015, to inter alia consider, approve and take on record the Audited Financial Results (Standalone and Consolidated) for quarter ended 30th June, 2022 and any other business items as per agenda circulated. You are requested to kindly take the same on your record.
06-08-2022
Bigul

Medico Intercontinental Ltd - 539938 - Announcement Under Regulation 30 - Reply To The Clarification Sought On Price Movement Of The Shares Of The Company.

 Dear Sir, With reference to your email dated 11/07/2022, we wish to inform you that the Company has made all the necessary disclosures pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information/event that in our opinion would have bearing on the price/volume behavior of the scrip. The Company shall continue to make applicable disclosures, within the stipulated time. Therefore, the increase in the share price / volume of the company is purely due to market conditions and absolutely market driven and the management of the company is in no way connected with any such increase in price / volume. You are requested to take the same on record.
12-07-2022
Bigul

Medico Intercontinental Ltd - 539938 - Clarification sought from Medico Intercontinental Ltd

 The Exchange has sought clarification from Medico Intercontinental Ltd on July 11, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
11-07-2022
Bigul

Medico Intercontinental Ltd - 539938 - Statement Of Investor Complaints For The Quarter Ended June 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- PUNEETA SHARMADesignation :- Company Secretary and Compliance Officer
04-07-2022
Bigul

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir / Ma'am, We are enclosing herewith the Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2022. Kindly take the above on your record.
02-07-2022
Bigul

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance with circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019 issued by BSE Limited, we wish to inform you that the 'Trading Window' for dealing in the securities of the Company has been closed and shall remain closed for all the designated persons and their immediate relatives till the conclusion of 48 hours after the declaration of financial results of the company for the quarter ended June 30, 2022. Accordingly, all designated persons and their immediate relatives of the Company have been advised not to trade in the securities of the Company during the aforesaid period of closure of trading window. You are requested to disseminate the above information on your website.
30-06-2022
Next Page
Close

Let's Open Free Demat Account